首页 > 抗体蛋白 > 抗体
FITC anti-mouse CD86 Antibody
产品名称:
FITC anti-mouse CD86 Antibody
产品类别:
抗体
产品编号:
105005
产品应用:
105005
[价格]
规格 价格 库存
50?g ¥ 1380 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
LPS-activated CBA/Ca mouse splenic B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The GL-1 antibody can block the mixed lymphocyte reaction in vitro and has been shown to inhibit the priming of cytotoxic T lymphocytes in vivo (along with antibodies against B7-1). Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemical staining of acetone-fixed frozen sections2,6, immunofluorescence microscopy, and in vivo and in vitro blocking of T cell responses1-6. GL-1 is not suitable for immunohistochemical staining of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 105051-105056).

Application References

(PubMed link indicates BioLegend citation)
  1. Hathcock KS, et al. 1993. Science 262:905. (Block, IP)
  2. Inaba KM, et al. 1994. J. Exp. Med. 180:1849. (Block, IHC)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Krummel MF, et al. 1995. J. Exp. Med. 182:459. (Block)
  5. Liu Y, et al. 1997. J. Exp. Med. 185:251. (Block)
  6. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  9. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  10. Klinger MB, et al. 2007. Am. J. Physiol. Requl. Integr. Comp. Physiol. 293:R677. PubMed
  11. de Verteuil DA, et al. 2014. J Immunol. 193:1121. PubMed
Product Citations
  1. Kawai H, et al. 2021. Asian Pac J Allergy Immunol. :. PubMed
  2. Kim EH, et al. 2020. Elife. 9:00. PubMed
  3. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  4. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  5. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  6. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  7. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  8. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  9. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  10. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  11. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  12. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  13. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  14. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  15. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  16. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  17. Yan H, et al. 2022. J Nanobiotechnology. 20:280. PubMed
  18. Cho H, et al. 2022. Nat Commun. 13:5974. PubMed
  19. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  20. Blank A, et al. 2021. J Pathol. 253:160. PubMed
  21. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  22. Ma J, et al. 2021. Curr Protoc. 1:e144. PubMed
  23. Chen X, et al. 2022. J Appl Oral Sci. 30:e20220316. PubMed
  24. Liang Y, et al. 2014. J Immunol. 192:1277. PubMed
  25. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  26. Tsang J, et al. 2011. Int Immunopharmacol. 11:604. PubMed
  27. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  28. Kurniawan H, et al. 2020. Cell Metabolism. 31(5):920-936. PubMed
  29. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  30. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  31. Pradhan K, et al. 2021. Front Immunol. 12:778830. PubMed
  32. Matundan H, et al. 2019. J Virol. 93. PubMed
  33. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  34. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  35. Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed
  36. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  37. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  38. Feng S, et al. 2021. Exp Ther Med. 21:20. PubMed
  39. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  40. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  41. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  42. Liu J, et al. 2021. Front Immunol. 12:733808. PubMed
  43. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  44. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  45. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  46. Moon Y, et al. 2022. Theranostics. 12:1999. PubMed
  47. Lin R, et al. 2022. Cell Death Dis. 13:345. PubMed
  48. Xue YL, et al. 2020. J Cell Mol Med. 24:12341. PubMed
  49. Smith LK, et al. 2021. Elife. 10:. PubMed
  50. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  51. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  52. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  53. Xu GY, et al. 2022. Small. 18:e2107838. PubMed
  54. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
  55. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  56. Aglas L, et al. 2018. J Allergy Clin Immunol. 142:984. PubMed
  57. Yá?ez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  58. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  59. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
RRID
AB_313148 (BioLegend Cat. No. 105005) AB_313149 (BioLegend Cat. No. 105006)

Antigen Details

Structure
Ig superfamily, 80 kD
Distribution

B cells and T cells (upregulated upon activation), macrophages, dendritic cells, and astrocytes

Function
T cell costimulation, Ig class-switching, NK cell cytotoxicity
Ligand/Receptor
CD28, CD152 (CTLA-4)
Cell Type
Astrocytes, B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Hathcock KS, et al. 1993. Science 262:905.
3. Freeman GJ, et al. 1993. Science 262:907.
4. Carreno BM, et al. 2002. Annu. Rev. Immunol. 20:29.

Gene ID
12524 View all products for this Gene ID
UniProt
View information about CD86 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线